Profil
John Le Gall is currently Chief Medical Officer at Imugene Ltd., starting in 2026.
Formerly, Dr. Le Gall was Vice President & Head-Clinical Development at Allogene Therapeutics, Inc. from 2023 to 2026.
Education includes an MBA and a doctorate from The Trustees of Columbia University in The City of New York.
Aktiva positioner av John Le Gall
| Företag | Position | Start |
|---|---|---|
| IMUGENE LIMITED | Teknisk/Vetenskaplig/F&U Direktör | 2026-10-07 |
Tidigare kända positioner av John Le Gall
| Företag | Position | Slut |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2026-01-01 |
John Le Galls utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
















